I’m on the market! 🎉
What do I do?
-I develop research questions and applied biotechnology to understand and disrupt insect symbioses.
-I coordinate international teams to tackle interdisciplinary global challenges.
-I train mycologists, entomologists and insect pathologists.
Helmsley convenes the Gut Cell Atlas Crohn’s Disease Consortium (GCA) annually. The GCA is generating a cellular atlas by cataloging the many cell types in the gastrointestinal tract with single-cell technologies. The atlas will provide novel insights into the cellular and molecular changes in Crohn’s disease, leading to improved diagnostics and treatments.
Find our insights from last year’s meeting, including updates from Dr. Shahida Din at The University of Edinburgh and Dr. Kathryn Hamilton at the Children's Hospital of Philadelphia here: https://t.co/x2kELmyIRp
#CrohnsDisease #SingleCellBiology #CellAtlas
Today is #WorldIBDDay2024!
Inflammatory bowel disease (IBD) -- Crohn’s disease and ulcerative colitis -- affects 7 million people worldwide. It is characterized by chronic inflammation of the gastrointestinal tract, and often severely impact people’s lives and well-being. At Helmsley, addressing the many unmet needs of people with Crohn’s disease drives our work as the largest private philanthropy focused on Crohn’s.
A commentary today in the The Lancet from leading experts, including Helmsley-supported researchers @DrRupaBanerjee1, @DrAilsaHart, @DrChrisLamb, and @IBDMD, highlights the importance of global collaboration in improving treatment strategies for IBD. Centering patient needs and insights is crucial for enhancing quality of life. https://t.co/RiQx1kGPrH
#IBDhasnoborders #CrohnsDisease #IBDawareness #GutHealth
If you’re at #DDW2024, check out the Helmsley-supported @PIANOIBD study presenting preliminary results from the first global consensus conference on pregnancy and inflammatory bowel disease.
A multidisciplinary team will prepare evidence-based recommendations surrounding all aspects of pregnancy in patients with IBD: from fertility, to pregnancy and delivery, to infant outcomes.
The session will be held on Sunday, May 19 at 10AM in Ballroom B, session #3210.
José Ordovás–Montañés, PhD, from Boston Children’s Hospital, is a member of the Gut Cell Atlas Crohn’s Disease Consortium, supported by Helmsley, which aims to generate a cellular atlas for Crohn’s disease by cataloging the many cell types in the small and large intestines with single-cell technologies. The atlas will provide novel insights into the cellular and molecular changes in Crohn’s disease, leading to improved therapeutics and diagnostics.
Learn more about the Gut Cell Atlas Crohn’s Disease Consortium: https://t.co/ahdxuCbI5G
Today we kicked off our Annual Convening of the #GutCellAtlas Crohn’s Disease Consortium. These scientific leaders are collaborating to map the gut using single-cell technologies, with the aim of improving our understanding of #CrohnsDisease.
Learn more about this extraordinary group: https://t.co/eob9E5yMbD
We were #HereForDDW#DDW2023, where our #CrohnsDisease team connected with many outstanding partners working to improve outcomes for people living with #Crohns and find a cure.
Last week, we hosted a roundtable discussion kicking off the @BowelUltrasound efforts to expand the use of intestinal ultrasound as a standard monitoring tool in US #IBD centers.
This week, we were excited to convene the #GutCellAtlas community, a diverse group of scientific leaders working to create a cellular map of the gut & enrich our understanding of #CrohnsDisease and #IBD. Find out more about this extraordinary group here: https://t.co/De9eQnYmXH
Researchers with the #HumanCellAtlas consortium report a major feat: the creation of detailed maps of more than a million individual cells across 33 organs, representing the most comprehensive, cross-tissue cell atlases to date.
Learn more in Science. ➡ https://t.co/X4bOfet8rq
We’re accepting LOIs for #IBD research grants of up to $150k. Our Innovator Awards have supported projects in areas such as diet & nutrition, the microbiome, therapeutic development & delivery, and more. https://t.co/pz8LMuJaUD
Proud of our team's hard work to present the first data to-date on COVID vaccines in IBD patients.
Serological response to COVID-19 vaccination in IBD patients receiving biologics https://t.co/Nl7agW8M6D
To cure, prevent or manage all diseases, scientific research should include people of all ancestries. That’s why @cziscience is launching a new RFA to increase tissue diversity in the @humancellatlas ⤵ https://t.co/a2Mg3ZMiAB
Only a few hours until #CCCongress21 begins! If you haven't registered yet, it's not too late. You can register & join us at any point over the course of the meeting (1/21-1/24). Click here to attend the premier meeting in #IBD: https://t.co/JrztWWI10p @AmerGastroAssn